Broad neutralization of SARS-related viruses by human monoclonal antibodiesAnna Z. Wec, Laura M. Walker, Juergen H. Nett et al.|Science|2020Cited by 645
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyC. Garrett Rappazzo, Laura M. Walker, Longping V. Tse et al.|Science|2021Cited by 394
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, Rohit K. Jangra, M. Eugenia Dieterle et al.|mBio|2021Cited by 61
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z. Wec, Laura M. Walker, Daniel Wrapp et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 28
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C. Garrett Rappazzo, Laura M. Walker, Longping V. Tse et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 20